Signaling
The COP9 signalosome (CSN) is a highly conserved multifunctional complex that regulates diverse biological responses (1). Jab1/CSN5 can interact with various proteins either as a monomer or as part of the CSN to regulate their functions. In order to understand the function of Jab1 in skeletal development, Chen et al. conditionally ablated the Jab1 gene in chondrocytes.
Jab1 deletion caused increased apoptosis, defects in cell cycle progression, and accelerated hypertrophic differentiation (2). This acceleration of hypertrophic differentiation could be due to the loss of the inhibitory effect of Jab1 on Runx2 activity and bone morphogenetic protein (BMP) signaling.
Several papers investigated the role of Notch signaling. The potential role of Notch signaling in skeletal development was first reported more than a decade ago (3), but its role in regulating the differentiation of osteoblast progenitor cells and chondrocytes has been better defined only recently (4;5 (18), these findings suggest that Ras/mitogenactivated protein kinase (MAPK) signaling regulates chondrocyte differentiation rather than proliferation.
Transcription Factors
Takashima et al. compared gene expression profiles of chondrogenic and nonchondrogenic cells, and identified Arid5b (AT-rich interactive domain 5b) as a cofactor of Sox9 (19) . Arid5b was coexpressed with Col2a1 and Sox9 in the developing limb. Arid5b-null mice showed defects in normal endochondral bone development with reduced proliferating chondrocytes. Using an in vitro assay, the authors demonstrated that Arid5b enhanced Sox9 function through a direct physical interaction.
The role of the Ets-related transcription factor, ERG, in mice was investigated by Ohta and colleagues (20) . This group previously showed that GDF5 stimulated ERG expression, and that ERG overexpression in chondrocytes suppressed chondrocyte differentiation and enhanced the characteristics of joint cartilage (21) . In this study, the consequences of the loss of ERG in joint cartilage were examined using joint-specific ERG knockout mice. ERG mutant mice showed normal growth but developed OA-like lesions. 
Epigenetics
Histone modification is one of the major epigenetic gene regulatory mechanisms. There have been 130 different histone modifications identified to date (22) . Among them, histone acetylation has been a major research subject. At the 2011 ASBMR Annual Meeting and in a previous paper, Bradley et al. demonstrated that conditional deletion of histone deacetylase 3 (HDAC3) in proliferating chondrocytes and osteoblasts using Osterix-Cre mice caused dwarfism and accelerated hypertrophic differentiation (23;24) . In addition, mutant mice showed a decrease in extracellular matrix production and a reduction in the size of hypertrophic chondrocytes, as well as a decrease in Akt/mTOR signaling, a major regulator of protein synthesis and cell size. Based on these findings, the authors propose that the impaired mTOR signaling in HDAC3 mutants was responsible for the reduced cell size and production of extracellular matrix. These are interesting observations, but certainly require follow-up regarding the mechanism by which HDAC3 deficiency impairs mTOR signaling. In addition, the notion that mTOR signaling regulates cell size of hypertrophic chondrocytes needs further verification.
HDAC4
physically binds to MEF2 transcription factors to prevent premature hypertrophic chondrocyte differentiation (25) . Previously, using an in vitro system, a model was proposed in which PTHrP signaling indirectly regulates HDAC4 activity to negatively control hypertrophic differentiation (26) . At this year's meeting, Nishimori et al. provided in vivo evidence supporting this model (27) . While the bones of heterozygous PTHrP-or HDAC4-null mice were normal, compound heterozygous mice showed significantly shorter growth plates, suggesting that PTHrP and HDAC4 regulate chondrocyte differentiation in a common pathway. In addition, the delayed chondrocyte differentiation in PTHrPtransgenic bones was normalized by simultaneous ablation of HDAC4.
Wang et al. investigated the role of PTHrP in thyroid hormone-induced hypertrophic differentiation (28) . Using an in vitro pellet culture system, they demonstrated that triiodothyronine (T3) increased both the expression and activity of Mef2c, and stimulated hypertrophic differentiation. T3 treatment increased HDAC4 phosphorylation and facilitated its nuclear export. PTHrP treatment antagonized these T3-induced effects.
Nakamura et al. investigated the potential role of HDAC4 in neural crest cell migration using zebrafish models (29) . HDAC4 knockdown resulted in craniofacial defects. These defects appeared to be caused at least in part by impaired neural crest cell migration demonstrated using Sox10-gfp and foxp2-gfp transgenic fish. Further investigation is required to determine whether this finding applies to mammals.
Histone H3 methylation regulates gene expression. The tri-methylation of lysine 27 of H3 (H3K27me3), catalyzed by the polycomb repressor complex 2 (PRC2), mediates chromatin silencing. Rankin et al. deleted the EED gene, an essential component of PRC2 in chondrocytes (30) . Loss of H3K27me3 modification caused a proliferation defect as well as hypoxiadependent cell death. The hypoxia-inducible factor (HIF) function in EED-deficient chondrocytes was reduced. This reduction in HIF function might be due to the upregulated aryl hydrocarbon receptor (AHR) that competes with HIFs for the common binding partner, aryl hydrocarbon receptor nuclear translocator (ARNT).
Matrix
Understanding the mechanisms of cartilage degradation is important for developing medical interventions for OA. Shen et al. reported that the matrix metalloproteinase MMP13 promoted OA development in OA IBMS BoneKEy. 2011 November;8(11):473-478 http://www.bonekey-ibms.org/cgi/content/full/ibmske;8/11/473 doi: 10.1138/20110541 mouse models in which either TGFβR2 was conditionally deleted or β-catenin was conditionally activated (31) . Simultaneous ablation of the MMP13 gene prevented OA development in these models. In addition, mice lacking either MMP13 in cartilage or treated with an MMP13 inhibitor exhibited decelerated meniscal-ligamentous injuryinduced OA.
Finally, Thuillier et al. reported an upregulation of MMP13 in chondrocytes with conditional deletion of Smad3, a major mediator of TGFβ signaling (32). Using an in vitro system, the authors demonstrated that Smad3 directly regulated MMP13 promoter activity.
Conclusion
As in other basic biomedical research fields, mouse genetics has become the dominant research method in bone and cartilage biology. In addition, thanks to the development of a plethora of specific chemical inhibitors and agonists, mouse models are becoming even more amenable to manipulation. As seen in presentations at the 2011 ASBMR Annual Meeting, sharing a common experimental system facilitated the removal of boundaries between developmental biologists, mouse geneticists and orthopedic researchers who have been studying cartilage and chondrocytes from different viewpoints. This trend will likely continue in the coming years.
